Articles & Commentary

Home > Publications > Articles & Commentary > Pharmaceuticals and the Worldwide HIV...

(2) | Saturday, November 21, 2009

Publications Books Articles & Commentary AEI Outlooks & On the Issues Speeches & Testimony Papers & Studies Press Releases Scholars Listing by A-Z Listing by Subject Adjunct Scholars List Events Upcoming Events Past Events Event Series Multimedia Research Areas Economic Policy Studies Foreign and Defense Policy Studies Health Policy Studies Legal and Constitutional Studies Political and Public Opinion Studies Social and Cultural Studies Projects AEI Center for Regulatory and Market Studies AEI Legal Center for the Public Interest AEI's Political Corner Center for Defense Studies Election Reform Project Global Governance Watch National Research Initiative Shadow Financial Regulatory Committee Iran Tracker Public Affairs Press Releases Speeches & Testimony Contact a Scholar Multimedia Support AEI Donate Now Individuals Foundations Corporations What Others Are Saying FAQ		EMAIL PRINT SAVE ARTICLES & COMMENTARY Pharmaceuticals and the Worldwide HIV Epidemic Can a Stakeholder Model Work? By John E. Calfee, Roger Bate \| Journal of Public Policy and Marketing Friday, October 1, 2004 Adoption of a stakeholder approach is likely to undermine essentialresearch and developmentwhile doing little to curtail the HIV/AIDS epidemic. Adoption of a stakeholder approach is likely to undermine essential research and development while doing little to curtail the HIV/AIDS epidemic. Roger Bate is a visiting fellow at AEI. John E. Calfee is a resident scholar at AEI.		Related Materials Health Policy Studies at AEI